1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Distribution of patients with cochleovestibular symptoms by VA size
VA Size Total (No.) MD (No.) Tinnitus (No.) Dizziness (No.) Vertigo (No.) Aural Fullness (No.)
<0.3 mm 52 5 9 6 6 0
0.3 mm ≤ × ≤0.7 mm 593 7 182 79 41 13
>0.7 mm 39 0 14 2 2 1
VA Size	Total (No.)	MD (No.)	Tinnitus (No.)	Dizziness (No.)	Vertigo (No.)	Aural Fullness (No.)
<0.3 mm	52	5	9	6	6	0
0.3 mm ≤ × ≤0.7 mm	593	7	182	79	41	13
>0.7 mm	39	0	14	2	2	1